- Home
- NNOX vs ESPR Comparison
NNOX vs ESPR Comparison
Compare NNOX & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- ESPR
- Stock Information
- Founded
- NNOX 2011
- ESPR 2008
- Country
- NNOX Israel
- ESPR United States
- Employees
- NNOX N/A
- ESPR N/A
- Industry
- NNOX Medical Electronics
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- ESPR Health Care
- Exchange
- NNOX Nasdaq
- ESPR Nasdaq
- Market Cap
- NNOX 302.9M
- ESPR 305.0M
- IPO Year
- NNOX 2020
- ESPR 2013
- Fundamental
- Price
- NNOX $5.24
- ESPR $0.80
- Analyst Decision
- NNOX Strong Buy
- ESPR Buy
- Analyst Count
- NNOX 2
- ESPR 7
- Target Price
- NNOX $12.00
- ESPR $5.93
- AVG Volume (30 Days)
- NNOX 900.4K
- ESPR 5.1M
- Earning Date
- NNOX 05-27-2025
- ESPR 05-06-2025
- Dividend Yield
- NNOX N/A
- ESPR N/A
- EPS Growth
- NNOX N/A
- ESPR N/A
- EPS
- NNOX N/A
- ESPR N/A
- Revenue
- NNOX $11,283,000.00
- ESPR $259,574,000.00
- Revenue This Year
- NNOX $105.67
- ESPR $5.70
- Revenue Next Year
- NNOX $177.95
- ESPR N/A
- P/E Ratio
- NNOX N/A
- ESPR N/A
- Revenue Growth
- NNOX 13.91
- ESPR 12.99
- 52 Week Low
- NNOX $3.75
- ESPR $0.82
- 52 Week High
- NNOX $11.00
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- NNOX 53.53
- ESPR 32.43
- Support Level
- NNOX $4.85
- ESPR $0.93
- Resistance Level
- NNOX $5.25
- ESPR $1.11
- Average True Range (ATR)
- NNOX 0.23
- ESPR 0.11
- MACD
- NNOX 0.05
- ESPR 0.01
- Stochastic Oscillator
- NNOX 72.73
- ESPR 17.93
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.